Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
Become a Member | Sign in
Home>News>This Article

Stanford Study Recruits Twins for Pharmacogenetic Study of Opiates

Published: Tuesday, November 11, 2008
Last Updated: Tuesday, November 11, 2008
Bookmark and Share
Investigators are recruiting twins for a study to determine whether addiction potential variations are due primarily to environmental factors or inherited traits.

Opiates such as morphine and codeine are the primary prescription medication for pain relief, but just how well these drugs work varies significantly from patient to patient. And no one really knows why.

Certain patients may require 10 times the amount of opiates, also known as narcotics, to get the same level of pain relief as others. Side effects such as nausea or sedation can be debilitating to some, while nonexistent for others. Addiction potential also varies from patient to patient.

“We rely heavily on narcotics as the cornerstone medication for the relief of moderate to severe pain,” said Martin Angst, MD, associate professor of anesthesia at the Stanford University School of Medicine and one of two principal investigators in a new study exploring individual variations in reactions to opiate use. “Yet we don’t know a lot of things, like why some people ‘like’ narcotics more than others - that could be key in determining addiction potential.”

In an attempt to determine whether these variations are due primarily to environmental factors or inherited traits, investigators at Stanford are recruiting twins for a study titled “Opiate efficacy: a twin study.” The three-year study, funded by the National Institutes of Health, requires 125 pairs of twins to come in for one day of work in the pain research laboratory at Stanford.

“The core of the study is really to provide insight into what should be done to improve narcotic use in the future,” said Angst, the lab’s director. David Clark, MD, PhD, associate professor of anesthesia, is the other principal investigator on the study.

“If the causes of individual variations are primarily environmental, it would make sense to conduct epidemiological studies,” Angst said. “If the causes are primarily genetic, the next step would be to invest in studies of the genome that could uncover key genes regulating pain and analgesic pathways. Such studies could uncover novel therapeutic targets and help guide the development of new pain medications. They could also lead to more rational pain therapies tailored to an individual’s genetic makeup thus reducing the risk of adverse events while optimizing pain control,” Angst said.

Twins who volunteer for the study will have their pain sensitivity measured by using a mild heat probe and by immersing a hand in ice-cold water, both before and during an infusion of the opiate alfentanil.

Researchers will also compare individual variations in levels of sedation, mental acuity, respiratory depression, nausea and drug-liking - a surrogate measure of addiction potential - between identical twins, non-identical twins and non-related subjects. This will provide an estimate of the extent to which variations in responses to opiates are inherited.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,700+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Key Mechanism in Gene Expression Discovered
RNA polymerase II makes life possible by expressing genes. Now, a team of Stanford biologists, chemists and applied physicists has observed it at work in real time.
Thursday, September 17, 2015
Scientists Home In On Origin Of Human, Chimpanzee Facial Differences
A study of species-specific regulation of gene expression in chimps and humans has identified regions important in human facial development and variation.
Monday, September 14, 2015
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Thursday, August 20, 2015
Identifying Defective Heart Genes
A new technique could eventually enable doctors to diagnose genetic heart diseases by rapidly scanning more than 85 genes known to cause cardiac anomalies.
Thursday, August 13, 2015
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Friday, July 31, 2015
Scientists Discern Signatures of Old Versus Young Stem Cells
A chemical code scrawled on histones determines which genes in that cell are turned on and which are turned off.
Wednesday, July 03, 2013
Stanford Scientist Omics Profile used to Discover, Track his Diabetes Onset
Researchers also spied on Dr Snyder's immune system and watched it battle viral infections.
Monday, March 19, 2012
Stanford Researchers Find Protein Targets for Potential Treatment of Multiple Sclerosis
Stanford researchers have identified therapy targets that could lead to personalized treatments for MS patients at each phase of the illness.
Monday, February 18, 2008
For Stanford Scientists, RNAi Gene Therapy Takes two Steps Forward, one Step Back
If RNAi is going to be viable as a therapy for organ-wide diseases such as hepatitis B or C, it will have to stick around.
Thursday, May 25, 2006
Gene Therapy for Muscular Dystrophy Fixes Frail Muscle Cells in Animal Model
Researchers used gene therapy to introduce a healthy copy of the gene dystrophin into mice with a condition that mimics muscular dystrophy.
Monday, January 02, 2006
Stanford Study Reveals Genetic Trigger Behind Some Schizophrenia Cases
The finding adds to mounting evidence of dopamine's link to psychiatric and neurological disorders.
Monday, October 24, 2005
Scientific News
Four New Genetic Disorders Identified
Sharing of genetic data empowers discovery of new disorders in children.
Biomarker Predicting Transplant Complications May be Key to Treating Them
A protein that can be used to predict if a stem cell transplant patient will suffer severe complications may also be the key to preventing those complications, an international research team based at the Indiana University School of Medicine reported Wednesday.
Chromosomal Chaos
Penn study forms basis for future precision medicine approaches for Sezary syndrome
Shaking Up the Foundations of Epigenetics
Researchers at the Centre for Genomic Regulation (CRG) and the University of Barcelona (UB) published a study that challenges some of the current beliefs about epigenetics.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,700+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos